Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know

Over the past five years immune-checkpoint inhibitors have dramatically changed the therapeutic landscape of advanced solid and hematologic malignancies. The currently approved immune-checkpoint inhibitors include antibodies to cytotoxic T-lymphocyte antigen-4, programmed cell death (PD-1), and prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Braschi-Amirfarzan, Marta, Tirumani, Sree Harsha, Hodi, Frank Stephen, Nishino, Mizuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2017
Materias:
Cancer Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240494/
https://www.ncbi.nlm.nih.gov/pubmed/28096717
http://dx.doi.org/10.3348/kjr.2017.18.1.42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240494/
https://www.ncbi.nlm.nih.gov/pubmed/28096717
http://dx.doi.org/10.3348/kjr.2017.18.1.42

Ejemplares similares